BioCentury

12:30 AM GMT, Aug 19, 2014
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Clinical News

NCI launches second precision medicine master protocol

The National Clinical Trials Network (NCTN) launched the ALCHEMIST protocol to identify early stage non-small cell lung cancer (NSCLC) patients with tumors that harbor genetic mutations to understand

Read the full 283 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.